BNTX.VI
BioNTech SE
ViennaEUREQUITY
Healthcare
DELAYED
Last price
100.90
▲ 6.15 (6.49%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
94.20
Prev close
94.75
Day high
101.60
Day low
94.20
Volume
555
Market cap
$25.35B
P/E (TTM)
—
52W range
68.65 – 104.00
Day trading desk
Gap from prior close
-0.58%
Prior close 94.75
VWAP
99.44
+1.47% from price
Relative volume
2.61×
Unusually busy
Session range
7.86%
94.20 – 101.60
Position in range
91%
Near session high
ATR (14D)
3.50
3.47% of price
Prior day high
95.05
PDH
Prior day low
92.10
PDL
Bid / ask spread
—
Quote not published
Session volume
555
Avg 213
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+26.84%
+28.2%
1M
+25.50%
+21.8%
3M
+26.76%
+23.7%
6M
+8.20%
-2.9%
YTD
+24.34%
+12.0%
1Y
+5.43%
-14.6%
3Y
-9.10%
-83.3%
5Y
-64.72%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on BNTX.VI open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
144.47M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Apr 22, 26 | POETTING SIERK Chief Operating Officer |
SELL | 50.00K | $5.53M | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
POETTING SIERK |
Chief Operating Officer | — | Sale |
Fundamentals
Market cap$25.35B
Enterprise value$12.20B
Revenue (TTM)$2.65B
Gross profit$2.03B
EBITDA$-1.38B
Net income$-1.69B
EPS (TTM)$-6.71
Free cash flow$-249.56M
Total cash$13.46B
Total debt$316.10M
Book value / share$70.69
Shares outstanding251.20M
Float108.42M
Short % of float—
Dividend yield—
Beta (5Y)1.28
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio0.05
Price / sales—
Price / book1.43
EV / revenue4.60
EV / EBITDA-8.84
Gross margin76.62%
Operating margin-806.63%
Profit margin-63.64%
Return on equity-9.30%
Return on assets-5.41%
Debt / equity1.78
Current ratio7.85
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.87B | $2.75B | $3.82B | $17.31B | +4.3% |
| Operating revenue | $2.87B | $2.75B | $3.82B | $17.15B | +4.3% |
| Cost of revenue | $641.80M | $541.30M | $599.80M | $3.00B | +18.6% |
| Gross profit | $2.23B | $2.21B | $3.22B | $14.32B | +0.8% |
| Research & development | $2.10B | $2.25B | $1.78B | $1.54B | -6.6% |
| Selling, general & admin | $698.20M | $712.70M | $587.10M | $541.20M | -2.0% |
| Total operating expense | $2.87B | $2.92B | $2.34B | $2.01B | -1.7% |
| Operating income | -$640.70M | -$709.40M | $875.60M | $12.30B | +9.7% |
| Net interest income | -$12.60M | -$17.20M | -$7.50M | -$18.90M | +26.7% |
| Pre-tax income | -$1.05B | -$677.70M | $1.19B | $12.95B | -55.1% |
| Tax provision | $85.30M | -$12.40M | $255.80M | $3.52B | +787.9% |
| Net income | -$1.14B | -$665.30M | $930.30M | $9.43B | -70.8% |
| Net income to common | -$1.14B | -$665.30M | $930.30M | $9.43B | -70.8% |
| Basic EPS | -4.70 | -2.77 | 3.87 | 38.78 | -69.7% |
| Diluted EPS | -4.70 | -2.77 | 3.83 | 37.77 | -69.7% |
| EBIT | -$1.04B | -$660.80M | $1.19B | $12.97B | -56.9% |
| EBITDA | -$653.80M | -$362.80M | $1.38B | $13.10B | -80.2% |
| Basic shares | 241.70M | 240.18M | 240.60M | 243.30M | +0.6% |
| Diluted shares | 241.70M | 240.18M | 242.70M | 249.80M | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $7.68B | $9.76B | $11.66B | $13.88B | -21.4% |
| Cash & short-term investments | $14.88B | $16.78B | $16.55B | $14.06B | -11.4% |
| Accounts receivable | $924.20M | $1.46B | $2.16B | $7.15B | -36.9% |
| Inventory | $110.70M | $283.30M | $357.70M | $439.60M | -60.9% |
| Total current assets | $16.15B | $18.80B | $19.53B | $21.92B | -14.1% |
| Property, plant & equipment | $1.29B | $1.18B | $971.60M | $821.10M | +9.1% |
| Goodwill & intangibles | $1.97B | $1.17B | $1.17B | $219.70M | +68.6% |
| Total assets | $21.99B | $22.53B | $23.01B | $23.28B | -2.4% |
| Total current liabilities | $2.14B | $2.52B | $2.07B | $2.95B | -15.1% |
| Current debt | $52.20M | $39.50M | $28.10M | $36.00M | +32.2% |
| Long-term debt | $215.20M | $214.70M | $191.00M | $176.20M | +0.2% |
| Total debt | $267.40M | $254.20M | $219.10M | $212.20M | +5.2% |
| Total liabilities | $2.76B | $3.12B | $2.76B | $3.22B | -11.4% |
| Retained earnings | $17.96B | $19.10B | $19.76B | $18.83B | -5.9% |
| Shareholder equity | $19.22B | $19.41B | $20.25B | $20.06B | -1.0% |
| Working capital | $14.00B | $16.28B | $17.46B | $18.97B | -14.0% |
| Net tangible assets | $17.25B | $18.24B | $19.08B | $19.84B | -5.4% |
| Shares issued | 259.03M | 248.55M | 248.55M | 248.55M | +4.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$1.05B | -$677.70M | $1.19B | $12.95B | — | -55.1% |
| Depreciation & amortisation | $382.80M | $298.00M | $183.40M | $123.30M | — | +28.5% |
| Stock-based compensation | $106.20M | $100.90M | $51.40M | $108.60M | — | +5.3% |
| Change in working capital | $537.80M | $1.22B | $5.57B | $4.52B | — | -55.9% |
| Operating cash flow | $456.00M | $207.70M | $5.37B | $13.58B | — | +119.5% |
| Capital expenditure | -$749.00M | -$452.30M | -$705.50M | -$363.30M | — | -65.6% |
| Investing cash flow | -$2.47B | -$2.08B | -$6.95B | -$35.30M | — | -18.6% |
| Share buybacks | $0 | $0 | -$738.50M | -$986.40M | — | — |
| Dividends paid | — | $0 | $0 | -$484.30M | $0 | — |
| Financing cash flow | -$52.90M | -$45.90M | -$778.60M | -$1.42B | — | -15.3% |
| Free cash flow | -$293.00M | -$244.60M | $4.67B | $13.21B | — | -19.8% |
| End cash position | $7.68B | $9.76B | $11.66B | $13.88B | — | -21.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $105.60M | $118.10M | $907.40M | $1.52B | $260.80M | -10.6% |
| Operating revenue | $51.90M | $66.90M | $1.12B | $1.47B | $153.30M | -22.4% |
| Cost of revenue | $97.00M | $71.40M | $333.30M | $148.30M | $76.40M | +35.9% |
| Gross profit | $8.60M | $46.70M | $574.10M | $1.37B | $184.40M | -81.6% |
| Research & development | $551.00M | $557.00M | $505.40M | $564.80M | $509.10M | -1.1% |
| Selling, general & admin | $197.80M | $163.80M | $291.70M | $148.50M | $137.40M | +20.8% |
| Total operating expense | $947.30M | $717.90M | $854.60M | $716.70M | $656.40M | +32.0% |
| Operating income | -$938.70M | -$671.20M | -$280.50M | $653.90M | -$472.00M | -39.9% |
| Net interest income | $62.70M | $57.00M | -$5.10M | -$300.00K | $64.00M | +10.0% |
| Pre-tax income | -$858.70M | -$568.10M | -$227.40M | $24.70M | -$402.70M | -51.2% |
| Tax provision | -$37.90M | -$36.20M | $77.60M | $53.40M | -$16.10M | -4.7% |
| Net income | -$820.80M | -$531.90M | -$305.00M | -$28.70M | -$386.60M | -54.3% |
| Net income to common | -$820.80M | -$531.90M | -$305.00M | -$28.70M | -$386.60M | -54.3% |
| Basic EPS | -3.24 | -2.10 | -1.25 | -0.12 | -1.60 | -54.3% |
| Diluted EPS | -3.24 | -2.10 | -1.25 | -0.12 | -1.60 | -54.3% |
| EBIT | -$855.20M | -$564.10M | -$676.40M | $653.90M | -$399.00M | -51.6% |
| EBITDA | -$589.10M | -$442.80M | -$511.60M | $778.10M | -$348.00M | -33.0% |
| Basic shares | 253.33M | 253.29M | 244.00M | 239.17M | 241.63M | +0.0% |
| Diluted shares | 253.33M | 253.29M | 244.00M | 239.17M | 241.63M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.74B | $9.94B | $7.68B | $10.09B | $10.27B | -2.0% |
| Cash & short-term investments | $14.78B | $14.64B | $14.88B | $14.52B | $14.04B | +1.0% |
| Accounts receivable | $163.90M | $539.20M | $924.20M | $690.80M | $1.37B | -69.6% |
| Inventory | $100.60M | $103.80M | $110.70M | $225.70M | $230.70M | -3.1% |
| Total current assets | $15.30B | $15.53B | $16.15B | $15.83B | $15.93B | -1.5% |
| Property, plant & equipment | $1.22B | $1.32B | $1.29B | $1.24B | $1.24B | -7.6% |
| Goodwill & intangibles | $1.79B | $1.92B | $1.97B | $1.75B | $1.85B | -6.4% |
| Total assets | $20.34B | $21.07B | $21.99B | $21.34B | $21.64B | -3.5% |
| Total current liabilities | $1.95B | $1.76B | $2.14B | $2.22B | $1.85B | +10.4% |
| Current debt | $57.20M | $10.80M | $52.20M | $53.40M | $52.40M | +429.6% |
| Long-term debt | $258.90M | $66.60M | $215.20M | $192.00M | $217.20M | +288.7% |
| Total debt | $316.10M | $302.80M | $267.40M | $245.40M | $269.60M | +4.4% |
| Total liabilities | $2.59B | $2.38B | $2.76B | $2.86B | $3.13B | +8.8% |
| Retained earnings | $16.61B | $17.43B | $17.96B | $18.27B | $18.30B | -4.7% |
| Shareholder equity | $17.76B | $18.70B | $19.22B | $18.48B | $18.51B | -5.0% |
| Working capital | $13.35B | $13.77B | $14.00B | $13.61B | $14.08B | -3.0% |
| Net tangible assets | $15.96B | $16.78B | $17.25B | $16.73B | $16.65B | -4.9% |
| Shares issued | 251.20M | 259.03M | 259.03M | 248.55M | 248.55M | -3.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$858.70M | -$568.10M | -$227.40M | $24.70M | -$402.70M | — | -51.2% |
| Depreciation & amortisation | $266.10M | $121.30M | $164.80M | $124.20M | $51.00M | — | +119.4% |
| Stock-based compensation | $20.90M | $22.80M | $24.10M | $27.90M | $32.10M | — | -8.3% |
| Change in working capital | $593.90M | $66.20M | -$227.40M | $644.00M | $519.70M | — | +797.1% |
| Operating cash flow | $10.50M | -$421.00M | $309.50M | $780.70M | $146.50M | — | +102.5% |
| Capital expenditure | -$55.40M | -$78.90M | -$62.10M | -$38.60M | -$30.20M | — | +29.8% |
| Investing cash flow | -$100.10M | $2.65B | -$2.73B | -$925.30M | -$64.40M | — | -103.8% |
| Share buybacks | -$129.20M | — | — | — | $0 | $0 | — |
| Financing cash flow | -$108.50M | $26.40M | -$14.30M | -$11.50M | -$13.30M | — | -511.0% |
| Free cash flow | -$44.90M | -$499.90M | $247.40M | $742.10M | $116.30M | — | +91.0% |
| End cash position | $9.74B | $9.94B | $7.68B | $10.09B | $10.27B | — | -2.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $1.06B | -30.0% |
| Next quarter | — | — | $503.38M | -44.5% |
| Current year | — | — | $1.81B | -37.0% |
| Next year | — | — | $1.84B | +2.0% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders57.51%
Held by institutions20.37%
Institutions holding476
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
85.06
+18.62% from price
SMA 20
82.66
+22.06% from price
SMA 50
81.38
+23.99% from price
SMA 100
81.42
+23.93% from price
SMA 200
84.09
+19.98% from price
EMA 12
86.73
+16.33% from price
EMA 26
83.61
+20.67% from price
EMA 50
82.21
+22.74% from price
RSI (14)
80.3
Overbought
MACD (12,26,9)
3.12
Hist 2.11
ATR (14)
3.50
3.47% of price
Realised vol 30D
57.8%
Annualised
Bollinger upper
94.92
20, 2σ
Bollinger lower
70.41
20, 2σ
50 / 200 cross
Death
81.38 vs 84.09
Trend bias
Above 200
+19.98%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.24
Less volatile than market
Correlation to SPY
0.06
Largely independent
Realised vol 30D
57.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-33.3%
Peak to trough
Max drawdown 5Y
-78.7%
Peak to trough
ATR 14
3.50
3.47% of price
Beta (reported)
1.28
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 5, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Aug 5, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Jul 8, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| May 27, 26 | UBS | UPGRADE | Neutral | Buy |
| May 22, 26 | Bernstein | INITIATED | — | Market Perform |
| May 6, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| May 6, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Apr 27, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Apr 10, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Mar 31, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Mar 11, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Mar 11, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
Headlines
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?
Motley Fool · 6m ago
Vistra Is the Quietest Big Winner of the AI Power Boom. Here's Why.
Motley Fool · 7m ago
AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?
Insider Monkey · 7m ago
Uber faces fine of nearly $1B over automated driver suspensions
TechCrunch · 16m ago
This Company Has Raised Its Dividend for 72 Straight Years. Almost Nobody Talks About It.
Motley Fool · 18m ago
This Chinese Tech Giant Quietly Cut Its Buyback 80% to Fund AI
24/7 Wall St. · 28m ago
Look Back: Long before Party on the Patio, Mötley Crüe rocked Pocono Downs
The Times-Leader (Wilkes-Barre, Pa.) · 29m ago
Prediction: ExxonMobil Raises Its Dividend More Than Wall Street Expects
Motley Fool · 30m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.